Skip to main content
  • Research Article
  • Open access
  • Published:

Does Splenectomy Protect Against Immune-Mediated Complications in Blunt Trauma Patients?

Abstract

Activation of the innate immune system results from severe trauma and the resultant systemic inflammatory response is thought to mediate remote organ injury. In animal models, vagal-mediated innate immune responses have been shown to modulate proinflammatory cytokine release in response to trauma or sepsis. In those models, vagal nerve transaction and splenectomy decreased cytokine release and protected against lung injury and mortality. We hypothesized that, if similar mechanisms are active in humans, patients who require splenectomy for trauma would have better outcomes than injured patients without splenectomy. We performed a retrospective cohort study on 46,858 patients who sustained blunt liver or spleen injury utilizing the 2002 National Trauma Data Bank (NTDB). Blunt trauma patients who underwent splenectomy were compared with all patients with splenic injuries. Demographic parameters and the following outcome variables were compared: mortality, hospital length of stay (LOS), ICU length of stay (ILOS), mean ventilator days (VENT), and incidence of acute respiratory distress syndrome (ARDS). Groups were compared controlling for age, gender, injury severity score (ISS), emergency department (ED) blood pressure, and ED base deficit (BD) using multiple regression analyses. Patients that underwent splenectomy had significantly shorter LOS than patients who were managed nonoperatively or with splenorrhaphy: LOS,15.1 versus 19.3 d, P = 0.002; ILOS,7.8 versus 10.6 d, P < 0.001; and VENT,7.1 versus 11.4 d, P < 0.001. Adjusted mortality rates (OR 1.02; 95% Cl 0.98–1.05; P = 0.29) and the reported incidence of ARDS were not significantly different between the two groups (2.4% versus 3.6%; P = 0.213). Patients who underwent splenectomy demonstrated better secondary outcomes than patients who were managed nonoperatively or with splenorrhaphy, even when controlling for injury severity and physiologic derangements. It is possible that the improved outcomes seen in the group undergoing splenectomy were due to favorable modulation of the human innate immune inflammatory response after trauma.

Introduction

The Center for Disease Control and Prevention (CDC) estimates that there are over 8 million nonfatal injuries caused by blunt trauma each year in the United States (1). Blunt abdominal trauma is a major source of morbidity and mortality and solid organs are particularly vulnerable to injury by virtue of their size and vascularity. The spleen is injured in up to 40% of blunt abdominal trauma. Severe splenic injury results in hemorrhagic shock and may lead to exsanguination because the spleen receives 5% of the cardiac output in adults, primarily via the splenic artery (2). However, the hemodynamically stable patient with blunt splenic injury does not absolutely require splenectomy. The experience with nonoperative management initially began in children and arose out of concern for development of overwhelming postsplenectomy sepsis (OPSS) from encapsulated organisms (3). Nonoperative management of splenic injuries in adults has reported success rates ranging from 68% to 83% in the largest series, and is now well-established as the mainstay of treatment in hemodynamically stable patients (4,5,6). The liver is injured in up to 30% of blunt abdominal trauma, but less commonly requires operation for hemostasis, with up to 80% of injuries now successfully managed nonoperatively (7).

Despite the increasing success of nonoperative management of blunt solid organ injuries, exploratory laparotomy with splenectomy or hepatorrhaphy is still the mainstay of care for the hemodynamically unstable patient with evidence of hemoperitoneum (8). This may lead to unanticipated immunologic consequences in addition to the known, delayed risk of OPSS (9), given the spleen’s increasingly evident role in immune modulation.

Splenic macrophages are a source of tumor necrosis factor (TNF) in response to an inflammatory stimulus (10). Concentration of TNF in the spleen is much higher than lung or liver concentrations after administration of lipopolysaccharide (LPS) in a rat model (11). Vagal nerve stimulation was found to attenuate this response to levels similar to nonstimulated controls (11). Recent animal models have helped to clarify the central, role of vagal-mediated, cholinergic modulation of the TNF response to sepsis (12). This pathway has been localized in mice to a local, α7-nicotinic acetylcholine receptor subunit on macrophages sequestered in the spleen during the onset of infection and sepsis (8,13). Splenectomy inactivates the cholinergic antiinflammatory pathway during endotoxemia and sepsis, and has been shown to decrease lethality of a septic insult in a murine model (14). If similar mechanisms are active in humans, patients who required emergent splenectomy for trauma may have very different spectra of inflammation-mediated morbidity than similarly injured patients without splenectomy. We hypothesized that splenectomy may lead to unanticipated immunologic effects in addition to the delayed risk of OPSS given the increasingly evident role of the spleen in immune modulation.

Materials and Methods

We performed a retrospective cohort study utilizing the National Trauma Data Bank (NTDB 2002, American College of Surgeons, Chicago, IL, USA). The NTDB is a multi-state database of trauma hospitalizations in the United States. This version contains approximately 450,000 records from 131 voluntarily contributing trauma centers. All data submitted to NTDB are de-identified and subjected to quality control using both the quality filters of the National Trauma Registry of the American College of Surgeons and a logical checks system set into place by the NTDB administrators. Permission was granted from the American College of Surgeons to query the data and Institutional Review Board approval was obtained at the home institution.

We identified a total of 46,858 blunt trauma patients reported to the NTDB who sustained either spleen or liver injuries. Of these, 28,002 individuals suffered blunt splenic injuries (59.8%) during the study period and 18,856 patients suffered hepatic injuries (40.2%). To determine the effects of operative intervention after blunt trauma on each specific solid organ, blunt trauma patients with expectantly managed splenic injuries were compared with the subset of patients who underwent splenectomy, and all patients with hepatic injuries were compared with the subset of patients undergoing hepatorrhaphy. In an effort to determine whether there were any immunogenic differences associated with operative intervention between these two solid organs after blunt trauma, we also compared the operative patients who underwent splenectomy to patients requiring hepatorrhaphy. The data set did not include any patients who underwent both splenectomy and hepatorrhaphy.

We limited the study population to patients who underwent their procedure within 12 h of injury to eliminate possible confounding effects from failure of nonoperative management, differences in perceived hemodynamic stability upon presentation, ongoing slow hemorrhage, and different transfusion practices.

Demographic parameters and the following outcome variables were compared: mortality, hospital length of stay (LOS), ICU length of stay (ILOS), ventilator d (VENT), and the incidence of acute respiratory distress syndrome (ARDS). Duration of VENT was tabulated only for patients who were ventilated mechanically at some time during the hospitalization. Mean and standard deviations were calculated and reported for these parameters.

Critical fields used for data analysis were ICD-9 injury codes (spleen 865.00-865.19, liver 864.00-864.19) and ICD-9-CM procedure codes (splenectomy 41.5, splenorrhaphy 41.43, liver laceration repair 50.61, other hepatic repair 50.69). Stata statistical software (College Station, TX, USA) was used to perform bivariate tabulated and subsequent multiple linear and logistic regression analyses with robust standard errors controlling for age, gender, Injury Severity Score (ISS), emergency department (ED) blood pressure, and ED base deficit (BD).

Results

We identified a total of 46,858 blunt trauma patients reported to the NTDB who sustained either spleen or liver injuries. Of these, 28,002 (59.8%) individuals suffered blunt splenic injury during the study period and 1,987 (7.1% of this subgroup) underwent splenectomy. Splenorrhaphy was performed in 48 patients (0.2% of this subgroup). Hepatic injury occurred in 18,856 patients (40.2% of total), with 578 (3.1%) undergoing laceration repair and 109 (0.6%) having some other type of hepatic repair. Operative intervention to control hemorrhage was more frequently needed in patients with splenic injuries than hepatic injuries (7.3% versus 3.6%; P < 0.05).

We performed bivariate analysis comparing splenic injury categories and hepatic injury categories individually and then with each other (Tables 1A, 1B). We found that the patients who underwent liver repair had a worse mean BD (−6.3 versus −5.0; P < 0.05) and slightly higher mean ISS (31.9 versus 30.2; P < 0.05) than patients who underwent splenectomy. Patients with splenic injuries overall also were more likely to be male than patients with hepatic injuries (66% versus 59%; P < 0.05). Patients who underwent splenorrhaphy had a lower ISS, and higher first ED systolic blood pressure (SBP), revised trauma score (RTS), and Glasgow Coma Score (GCS) than the rest of the injured spleen group (P < 0.05). No other within- or between-group demographic comparisons were statistically significant including age, first ED SBP, ED temperature (ED Temp), GCS, RTS, race, or payment source. Not surprisingly, unadjusted mortality was lower for patients with splenic injury that did not require splenectomy. However, we found that splenectomy survivors had shorter LOS, ILOS, and VENT (Table 2).

Table 1A Summary demographics of 2002 NTDB patients with blunt splenic or liver injury.a
Table 1B Injury severity, physiologic markers, and social history demographics of 2002 NTDB patients with blunt splenic or liver injury.a
Table 2 Unadjusted Outcomes of 2002 NTDB patients with blunt splenic or liver injury.a

Multivariate linear regression analysis showed that patients undergoing splenectomy had significantly better secondary outcomes than the overall population of all patients with splenic injuries (P < 0.05 for LOS, ILOS, and VENT). Mortality, however, was not impacted when controlling for injury severity (OR 1.02; 95% CI 0.98–1.05; P = 0.29). Patients who underwent hepatorrhaphy did not demonstrate any significant differences for either mortality or the secondary outcomes from the overall group of patients with liver injuries. The reported incidence of ARDS was very low overall and was not significantly different between any of the groups when controlling for severity of illness.

In multivariate models, patients who underwent splenectomy had a lower overall mortality (OR 0.73; 95% CI 0.54–0.89; P < 0.001) than patients who underwent hepatorrhaphy. Furthermore, despite similar overall injury severity, patients that had splenectomy were found to have better secondary outcomes than patients undergoing hepatorrhaphy. Multiple linear regression showed that splenectomized patients had significantly shorter LOS (15.1 versus 18.0 d; P = 0.002), ILOS (7.8 versus 10.1 d; P < 0.001), and VENT (7.1 versus 14.3 d; P < 0.001).

Discussion

In an attempt to determine whether the spleen had a major role in an acute ‘inflammatory reflex’ after traumatic injury, we tried to take advantage of the ‘natural experiment’ arising out of routine care of intra-abdominal injuries reported to the NTDB. Using a large retrospective cohort, we found no statistically significant difference in mortality for patients with splenic injury who underwent splenectomy compared with patients with splenic injuries managed nonoperatively or with splenorrhaphy. Our findings are consistent with the widespread acceptance of the safety and efficacy of nonoperative management of splenic injuries (4,15). However, our surprising finding was that patients who underwent splenectomy had significantly shorter hospital LOS, VENT, and ICU days than the splenorrhaphy or nonoperativelymanaged groups, even when controlling for injury severity and patient demographics. It is possible that splenectomy after trauma may decrease TNF production and may ameliorate acute inflammation via modulation of the innate immune response after trauma. Although this interpretation of the data supports our hypothesis, the scope of this study and the nature of the data available from the NTDB did not permit us to assess for alteration in immune modulation.

There are several limitations to this study. First, these data are derived from a clinical database not generated specifically for this type of analysis. This study relies on medical records coding to assign diagnoses, demographics, and outcomes. Hence, systematic errors in diagnostic coding might result in misleading data interpretation and conclusions. However, this particular database has been used reliably for other trauma research (16,17,18,19), and is the largest database of its kind available for analysis. There are several methodologic concerns that are specific to this data set including heterogeneity of the contributing institutions and geographic variations in trauma practice patterns. Contributors to the data set include rural and urban centers, as well as teaching and nonteaching centers. This concern has been addressed in a recent study by Nathens et al. that examined variation among trauma centers using the NTDB. They found that the parameters we included, such as ISS, age, and SBP, accounted for most of the variation between trauma center mortality rates, irrespective of trauma center level designation or hospital teaching status (20).

A second limitation is that the management of blunt splenic and hepatic injuries continues to evolve and our data query involved information from 2002. Detailed information on transfusions, transfusion protocols, and angioembolization are not available from this data set. No information is available from the database regarding ICU or ventilator management, nor is it possible to obtain any direct information about intra-operative findings. The low incidence of ARDS reported to the NTDB in our sample is somewhat surprising, given the very high ISS in the study population. This version of the NTDB also did not record complete information about other manifestations of posttraumatic MODS, such as acute renal failure, nosocomial infections, or need for vasopressors, so the impact of splenectomy on any of these potentially immune-mediated outcomes could not be assessed. The overall severity of injury is reflected in the fact that LOS and ILOS were quite prolonged in all patient cohorts (operative versus nonoperative and spleen injury versus liver injury). This finding also supports the hypothesis that the traumatic insult elicited a significant and prolonged proinflammatory innate immune response.

A small subset of patients reported to the NTDB underwent splenorrhaphy and information for these patients is included. It is noteworthy that the subset of patients undergoing operative splenic intervention had short LOS and ILOS, although they had an intact spleen. Although this might seem to contradict our hypothesis, this subgroup was also younger (30 versus 36.1), had a lower ISS (21.9 versus 31.2), and a higher ED systolic blood pressure (121 versus 114).

The innate immune system is essential for protection against lethal infections. Endotoxin and other pathogens stimulate the production of proinflammatory cytokines, including TNF (21). Through mechanisms which help localize and contain invasive organisms, TNF is essential for host defenses (22,23). However, the magnitude of the inflammatory response appears to be a critical factor determining outcome. Unmodulated inflammation can lead not only to autoimmune disorders like Crohn’s Disease (24) or rheumatoid arthritis (25), but also can cause the extensive tissue damage and hemodynamic compromise associated with traumatic injury (26). Examples of clinically significant morbidities that may be meditated by excessive proinflammatory cytokines include septic shock and ARDS (27,28,29).

In summary, we found that patients who underwent splenectomy had a lower mortality, a shorter duration of pulmonary failure (decreased VENT), and shorter ILOS and LOS than similarly injured patients. Further studies need to be done, particularly with tissue and biologic samples posttrauma and post-splenectomy, measuring cytokine levels, and correlating results with outcomes to better ascertain the immunomodulatory role of the spleen in posttraumatic pro- and antiinflammatory pathways.

Disclosures

We declare that the authors have no competing interests as defined by Molecular Medicine, or other interests that might be perceived to influence the results and discussion reported in this paper.

References

  1. Centers for Disease Control and Prevention [Internet]. Atlanta, GA: CDC; [updated April 1, 2009; cited May 5, 2009]. Available from: http://www.cdc.gov/InjuryViolenceSafety/. See “WISQARS.”

  2. Eichner E. (1979). Splenic function: Normal, too much, and too little. Am. J. Med. 66:311.

    Article  CAS  Google Scholar 

  3. Bisharat N, Omari H, Lavi I, Raz R. (2001). Risk of infection and death among post-splenectomy patients. J. Infect. 43:182–6.

    Article  CAS  Google Scholar 

  4. Cogbill TH, et al. (1989). Nonoperative management of blunt splenic trauma: a multicenter experience. J. Trauma 29:1312–7.

    Article  CAS  Google Scholar 

  5. Peitzman AB, et al. (2000). Blunt splenic injury in adults: multi-institutional study of the Eastern Association for the Surgery of Trauma. J. Trauma. 49:187–9.

    Article  Google Scholar 

  6. Myers JG, et al. (2000). Blunt splenic injuries: dedicated trauma surgeons can achieve a high rate of nonoperative success in patients of all ages. J. Trauma. 48:801–5; discussion 805–6.

    Article  CAS  Google Scholar 

  7. Boone D, Federle M, Billiar T, Udekwu A, Peitzman A. (1995). Evolution of management of major hepatic trauma: identification of patterns of injury. J. Trauma 39:344–50.

    Article  CAS  Google Scholar 

  8. Fabian T, Croce M. (2000) Abdominal Trauma, including Indications for Celiotomy. In: Trauma. Mattox K, Feliciano D, Moore E (eds.) McGraw-Hill, New York, pp. 583–600.

    Google Scholar 

  9. Singer DB. (1973) Postsplenectomy sepsis. Per-spect. Pediatr. Pathol. 1973;1:285–311.

    CAS  Google Scholar 

  10. Henry G, Garner WL. (2003) Inflammatory mediators in wound healing. Surg. Glin. North Am. 83:483–507.

    Article  Google Scholar 

  11. Huston JM, et al. (2006). Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J. Exp. Med. 203:1623–8.

    Article  CAS  Google Scholar 

  12. Pavlov VA, et al. (2006) Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia. Proc. Natl. Acad. Sci. U. S. A., 103:5219–23.

    Article  CAS  Google Scholar 

  13. Parrish WR, et al. (2008) Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholine receptor-mediated signaling. Mol. Med. 14:567–74.

    Article  CAS  Google Scholar 

  14. Huston JM, et al. (2008) Splenectomy protects against sepsis lethality and reduces serum HMGB1 levels. J. Immunol. 181:3535–9.

    Article  CAS  Google Scholar 

  15. Croce MA, et al. (1995) Nonoperative management of blunt hepatic trauma is the treatment of choice for hemodynamically stable patients: results of a prospective trial. Ann. Surg. 221:744–53; discussion 753–5.

    Article  CAS  Google Scholar 

  16. Knudson MM, Ikossi DG, Khaw L, Morabito D, Speetzen LS. (2004) Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank. Ann. Surg. 240:490–6; discussion 496–8.

    Article  Google Scholar 

  17. McGwin G, Jr, MacLennan PA, Fife JB, Davis GG, Rue LW, 3rd. (2004) Preexisting conditions and mortality in older trauma patients. J. Trauma 56:1291–6.

    Article  Google Scholar 

  18. Millham FH, LaMorte WW. (2004) Factors associated with mortality in trauma: re-evaluation of the TRISS method using the National Trauma Data Bank. J. Trauma 56:1090–6.

    Article  Google Scholar 

  19. Nirula R, Gentilello LM. (2004) Futility of resuscitation criteria for the “young” old and the “old” old trauma patient: a national trauma data bank analysis. J. Trauma 57:37–41.

    Article  Google Scholar 

  20. Nathens A, Xiong W, Shafi S. (2008) Ranking of trauma center performance: the bare essentials. J. Trauma 65:628–35.

    Article  Google Scholar 

  21. Cinel I, Opal SM. (2009) Molecular biology of inflammation and sepsis: a primer. Grit. Gare Med. 37:291–304.

    Article  CAS  Google Scholar 

  22. Mira JP, et al. (1999) Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality. JAMA 282:561–8.

    Article  CAS  Google Scholar 

  23. Waterer GW, et al. (2001) Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations. Grit. Gare Med. 163:1599–603.

    CAS  Google Scholar 

  24. Podolsky D. (2002) Inflammatory bowel disease. N. Engl. J. Med., 347:417–29.

    Article  CAS  Google Scholar 

  25. Choy EHS, Panayi GS. (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N. Engl. J. Med. 344:907–16.

    Article  CAS  Google Scholar 

  26. Baue AE, Durham R, Faist E. (1998) Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock 10:79–89.

    Article  CAS  Google Scholar 

  27. Angus DC, Wax RS. (2001) Epidemiology of sepsis: an update. Grit. Gare Med. 29(7 Suppl):S109–16.

    Article  CAS  Google Scholar 

  28. Tracey KJ. (2007) Physiology and immunology of the cholinergic antiinflammatory pathway. J. Glin. Invest. 117:289–96.

    Article  CAS  Google Scholar 

  29. Phua J, Stewart TE, Ferguson ND. (2008). Acute respiratory distress syndrome 40 years later: time to revisit its definition. Grit. Gare Med. 36:2912–21.

    Article  Google Scholar 

  30. Crandall M, Shapiro M, West M. Splenectomy protects against immune-mediated complications in blunt trauma patients [abstract]? Surg. Infect. (Larchmt) 2008;9:310.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marie Crandall.

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Crandall, M., Shapiro, M.B. & West, M.A. Does Splenectomy Protect Against Immune-Mediated Complications in Blunt Trauma Patients?. Mol Med 15, 263–267 (2009). https://doi.org/10.2119/molmed.2009.00029

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2119/molmed.2009.00029

Keywords